In 2009, PHI awarded $25,000 to team from University of Insubria, Varese, Italy, led by Antonio Toniolo, MD, PhD, Professor of Medical Microbiology and Virology.
Final Report
Antonio Toniolo, MD; Andreina Baj, MD; Giuseppe Maccari, MS - Laboratory of Medical Microbiology and Virology, Department of Clinical and Biological Sciences, University of Insubria Medical Center, Varese, Italy
Read More…
Barbara C. Sonies, PhD, CCC, BRS-S, College Park, Maryland
A major polio epidemic in the mid-20th century left many survivors with a wide variety of physical limitations including problems swallowing foods. Many persons with swallowing problems also had original bulbar signs of polio including difficulty breathing, clearing the throat, speaking and singing.
Read More…
PHI awarded $25,000 each to two research groups in 2011. This is the report from the University of Michigan.
Claire Z. Kalpakjian, PhD, MS, University of Michigan, Department of Physical Medicine and Rehabilitation, Ann Arbor, Michigan
Read More…
Joan L. Headley, Executive Director, PHI
In late 2013, Post-Polio Health International awarded $100,000 to the team of Antonio Toniolo, MD; Andreina Baj, MD; Martina Colombo, PhD – Laboratory of Medical Microbiology and Virology, Department of Biotechnology and Life Sciences, University of Insubria Medical Center, Varese, Italy, to expand its search for poliovirus genome in various populations.
Read More…
Joan L. Headley, Executive Director, Post-Polio Health International
Typical of most studies, the name of the most recently announced study related to post-polio syndrome is long but exactingly descriptive: A Multicenter, Prospective, Randomized, Placebo-controlled, Double-blind, Parallel-Group Clinical Trial to Assess the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients with Post-Polio Syndrome.
Read More…